Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Torre, L. A. et al. World most cancers statistics, 2012. CA Most cancers J. Clin. 65, 87–108. https://doi.org/10.3322/caac.21262 (2015).Article
PubMed
...
